Capital Performance Advisors LLP Abbott Laboratories Transaction History
Capital Performance Advisors LLP
- $325 Million
- Q3 2024
A detailed history of Capital Performance Advisors LLP transactions in Abbott Laboratories stock. As of the latest transaction made, Capital Performance Advisors LLP holds 1,868 shares of ABT stock, worth $221,544. This represents 0.07% of its overall portfolio holdings.
Number of Shares
1,868Holding current value
$221,544% of portfolio
0.07%Shares
1 transactions
Others Institutions Holding ABT
# of Institutions
3,167Shares Held
1.33BCall Options Held
8.63MPut Options Held
7.19M-
Vanguard Group Inc Valley Forge, PA166MShares$19.7 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$15.6 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.82 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8.52 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.79 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $208B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...